Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
Regeneron Pharmaceuticals Inc · PHARMACEUTICAL PREPARATIONS · Now $600.66
+3.1% in 1d after detection
Post-detection moves
1h
—
1d
+3.1%
3d
+1.4%
7d
-2.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS